Investors are closely monitoring the performance of Indian pharma companies in the March 2025 quarter and their ability to ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Global pharmaceutical company Pfizer (NYSE:PFE) in Q1 CY2025, with sales falling 7.8% year on year to $13.72 billion. The ...

MADRID, May 12 (Reuters) - Grifols's net profit almost tripled from a year earlier, which the Spanish drugmaker said ...

Stock futures soared on Monday after a trade deal to substantially lower tariffs was reached with China over the weekend. According to a joint statement, Trump's "reciprocal" tariffs on China will ...

But when a dividend yield reaches ultrahigh levels, investors can feel a heightened level of uncertainty. Wondering if Pfizer ...

Royal Caribbean Group reported first-quarter earnings that rose above expectations, and was one of the rare companies to raise their full-year outlook in the face of “heightened” uncertainties ...

We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to ...

A quickly evolving political landscape and challenges to reliable revenue streams led major for-profit providers to exercise ...

Novo Nordisk's stock has plummeted over 60%, while also arguably losing market share to Eli Lilly. Click here to find out why ...

Management updated its 2025 revenue guidance to $72-$74 million, representing 25% growth at the midpoint. Plasma revenue is expected to decline by 8%-10%, while pharma revenue is projected to grow ...